跳至主要内容
临床试验/NCT06486805
NCT06486805已完成4 期

The Effect of N-Acetylcysteine on Liver Functions After Mitral Valve Replacement: A Randomized Controlled Trial

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Malondialdahyde (MDA)

研究概览

简要总结

This study aimed at the impact of the N-acetyl cysteine on the improvement of liver function subsequently on-pum mitral valve replacement. Following a clinical trial design, 54 candidates of on-pump MVR, aged 18 to 70 years, with normal liver and renal function were selected. The candidates were randomly divided into intervention: IV150 mg/ kg N-acetyl cysteine over 15 min, and control groups (normal saline as placebo) (n = 27 in each group).

详细描述

In a randomized controlled prospective study conducted in a teaching hospital, after approval by the ethics committee and informed consent, 54 candidates for on-pump MVR, aged 18 to 70 years, with normal liver and renal function, were selected. The candidates were randomly divided into intervention: IV 150 mg/ kg N-acetyl cysteine over 15 min then 50 mg/kg over 4 hrs for 3 days, and control groups (normal saline as placebo) (n = 27 in each group).and we will assess the effect of NAC on intra-operative hemodynamics and post-operative its protective rule against oxidative stress and liver dysfunction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

quadrible blinded

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 70 years
  • Both sexes
  • Patients undergoing on-pump elective MVR with cold cardioplegia.

排除标准

  • Patient refusal.
  • Allergy to any of the study medications.
  • Emergency procedures.
  • systolic dysfunction, left ventricular ejection fraction <40%.
  • Pre-existing hepatic dysfunction, which is defined as an increase in liver enzymes AST and ALT >10 times the baseline.
  • chronic use of drugs affecting liver functions, e.g., NSAIDs, steroids, and anticonvulsants.

研究组 & 干预措施

control

Placebo Comparator

received the same volume of normal saline as placebo

干预措施: normal saline (Other)

NAC

Active Comparator

received 150 mg/kg NAC in 200 ml of 5% glucose over 15 min through the central line after induction of anesthesia and intubation followed by 50 mg/kg of NAC in 500 ml of 5% glucose over 4 h

干预措施: N acetyl cysteine (Drug)

结局指标

主要结局

Malondialdahyde (MDA)

时间窗: Postoperative day one

MDA is a marker of oxidative stress and one of the end-products of lipid peroxidation. MDA level reflects the degree of lipid peroxidation.

次要结局

  • liver function tests(preoperative ,first ,and,second post operative days)
  • hemodunamics(intraoperative)
  • tissue perfusion(preoperative ,first ,and,second post operative days)
  • MDA(preoperative and second postoperative day)
  • extubation time(postoperative 24 hr.)

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Mohamed Elhaddad

Assisstent professor

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验

N-Acetyl Cysteine Effect on Liver Function After... | 临床试验